Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Trust NASDAQ 100 Technology Index Fund (QTEC) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance

First Trust NASDAQ 100 Technology Index FundTrade
Royalty Pharma plc Class A Ordinary SharesTrade

Price performance (Past 24H)

Key statistics

First Trust NASDAQ 100 Technology Index Fund vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? First Trust NASDAQ 100 Technology Index Fund trades at $330.45 (market cap $4.10B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.79 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 6.2× First Trust NASDAQ 100 Technology Index Fund's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while First Trust NASDAQ 100 Technology Index Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold First Trust NASDAQ 100 Technology Index Fund for 40 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.

QTECRPRX
Market Cap
$4.10B$25.27B
Volume
264,3033,671,183
Sector
Broad Market / FactorHealth
52-Week High
$340.28$63.96
52-Week Low
$207.03$35.44
Typical Hold Time
40 Days0 Days
Enterprise Value
—$32.50B
Dividend Yield
—1.66%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Trust NASDAQ 100 Technology Index Fund

QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $335.82, down 1.31% on the day. Technical indicators show a bullish trend from moving averages but caution from overbought RSI levels. The ETF provides equal-weighted exposure to the technology sector, with recent analysis highlighting its broader sector definition and liquidity advantages.

The outlook for QTEC is supported by bullish technical trends and its role in tech exposure, though overbought conditions and sector volatility present risks. Investment opportunity lies in diversified tech access, but investors face market sensitivity and valuation pressures inherent to technology stocks.

Royalty Pharma plc Class A Ordinary Shares

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QTEC
0% Buy100% Sell
Avg holding period · 40 Days
RPRX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About First Trust NASDAQ 100 Technology Index Fund

QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.

Read more on QTEC →

About Royalty Pharma plc Class A Ordinary Shares

Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.

Read more on RPRX →